7 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
19 Oct 22
Departure of Directors or Certain Officers
4:05pm
placed on paid leave pending the outcome of this matter.
Under the renewed leadership of Mr. Hull, Maravai will continue to serve its customers
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
1 Dec 22
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
4:26pm
placement on a paid leave of absence as a result of a lawsuit claiming violation of a noncompetition agreement filed by two of Martin’s former
8-K
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
1 Dec 22
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
4:26pm
, Mr. Martin was appointed Chief Executive Officer of the Company on September 30, 2022, but was placed on a paid leave of absence on October 18, 2022
8-K
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
19 Oct 22
Departure of Directors or Certain Officers
4:05pm
“Trey” Martin, III, Chief Executive Officer, on a paid leave of absence following the issuance of a temporary restraining order by the Delaware Court
- Prev
- 1
- Next